LANCE ALSTODT - 14 Feb 2025 Form 4 Insider Report for BioRestorative Therapies, Inc. (BRTX)

Role
President, CEO, COB, Director
Signature
/s/ Lance Alstodt
Issuer symbol
BRTX
Transactions as of
14 Feb 2025
Transactions value $
$0
Form type
4
Filing time
19 Feb 2025, 16:22:47 UTC
Previous filing
20 Mar 2024
Next filing
20 Oct 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BRTX Common Stock 171,872 14 Feb 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BRTX Stock Option Award $0 +791,885 $0 791,885 14 Feb 2025 Common Stock 791,885 $2.46 Direct F4
holding BRTX Stock Option 293,479 14 Feb 2025 Common Stock 293,479 $5.08 Direct F1
holding BRTX Stock Option 42,059 14 Feb 2025 Common Stock 42,059 $5.08 Direct F1
holding BRTX Stock Option 106,762 14 Feb 2025 Common Stock 106,762 $2.91 Direct F2
holding BRTX Stock Option 438,596 14 Feb 2025 Common Stock 438,596 $1.45 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is currently exercisable.
F2 The option vests and becomes exercisable to the extent of 53,381 shares on February 17, 2023 and 53,381 shares in eight nearly equal quarterly installments beginning February 17, 2024 and continuing every three months thereafter until fully vested.
F3 The option vests and becomes exercisable to the extent of 219,298 shares on February 13, 2024 and 219,298 shares in eight nearly equal quarterly installments beginning February 13, 2025 and continuing every three months thereafter until fully vested.
F4 The options vests and becomes exercisable to the extent of 395,943 shares on February 14, 2025 and 395,942 shares in eight nearly equal quarterly installments beginning February 14, 2026 and continuing every three months thereafter until fully vested.